RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mega Lifesciences PCL - Stock

Mega Lifesciences PCL Debt 2024

Mega Lifesciences PCL Debt

-2,104.89 THB

Ticker

MEGA.BK

ISIN

TH4984010009

In 2024, Mega Lifesciences PCL's total debt was -2,104.89 THB, a 3.56% change from the -2,032.59 THB total debt recorded in the previous year.

Mega Lifesciences PCL Aktienanalyse

What does Mega Lifesciences PCL do?

Mega Lifesciences PCL is a global healthcare company focused on innovative solutions and products for improving the health and well-being of people. It was founded in 1984 and is based in Bangkok, Thailand. The company operates in over 30 countries worldwide and employs over 5,000 employees. It started as a distribution-focused company but soon began developing its own products, starting with a dietary supplement called Bio-C Plus. Mega Lifesciences has grown through acquisitions and expanded its product portfolio. Its business model focuses on nutrition, health, and wellness, with a strong presence in Asia, Africa, Europe, and Latin America. The company is divided into different divisions including healthcare products, dietary supplements, veterinary medicine, and licensed products. Some of its products include Megaheart for cardiovascular diseases, Megamycin as an antibiotic, Megavit as a dietary supplement, Megaderm for skin diseases in animals, and licensed products from international pharmaceutical and healthcare companies. Mega Lifesciences aims to improve people's lives and promote their health through its diverse range of products. Mega Lifesciences PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Mega Lifesciences PCL's Debt Structure

Mega Lifesciences PCL's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Mega Lifesciences PCL's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Mega Lifesciences PCL’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Mega Lifesciences PCL’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Mega Lifesciences PCL Stock

What is the debt of Mega Lifesciences PCL this year?

Mega Lifesciences PCL has a debt level of -2,104.89 THB this year.

What was the debt of Mega Lifesciences PCL compared to the previous year?

The debt of Mega Lifesciences PCL has increased by 3.56% compared to the previous year increased.

What are the consequences of high debt for investors in Mega Lifesciences PCL?

High debt can pose a risk for investors of Mega Lifesciences PCL, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Mega Lifesciences PCL?

Low debt means that Mega Lifesciences PCL has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Mega Lifesciences PCL affect the company?

An increase in debt of Mega Lifesciences PCL can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Mega Lifesciences PCL affect the company?

A reduction in debt of Mega Lifesciences PCL can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Mega Lifesciences PCL?

Some factors that can influence the debt of Mega Lifesciences PCL include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Mega Lifesciences PCL so important for investors?

The debts of Mega Lifesciences PCL are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Mega Lifesciences PCL take to change the debt?

To change the debt, Mega Lifesciences PCL can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Mega Lifesciences PCL pay?

Over the past 12 months, Mega Lifesciences PCL paid a dividend of 1.65 THB . This corresponds to a dividend yield of about 4.49 %. For the coming 12 months, Mega Lifesciences PCL is expected to pay a dividend of 1.99 THB.

What is the dividend yield of Mega Lifesciences PCL?

The current dividend yield of Mega Lifesciences PCL is 4.49 %.

When does Mega Lifesciences PCL pay dividends?

Mega Lifesciences PCL pays a quarterly dividend. This is distributed in the months of September, April, September, April.

How secure is the dividend of Mega Lifesciences PCL?

Mega Lifesciences PCL paid dividends every year for the past 13 years.

What is the dividend of Mega Lifesciences PCL?

For the upcoming 12 months, dividends amounting to 1.99 THB are expected. This corresponds to a dividend yield of 5.41 %.

In which sector is Mega Lifesciences PCL located?

Mega Lifesciences PCL is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mega Lifesciences PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mega Lifesciences PCL from 4/22/2024 amounting to 0.8 THB, you needed to have the stock in your portfolio before the ex-date on 3/6/2024.

When did Mega Lifesciences PCL pay the last dividend?

The last dividend was paid out on 4/22/2024.

What was the dividend of Mega Lifesciences PCL in the year 2023?

In the year 2023, Mega Lifesciences PCL distributed 0.45 THB as dividends.

In which currency does Mega Lifesciences PCL pay out the dividend?

The dividends of Mega Lifesciences PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mega Lifesciences PCL

Our stock analysis for Mega Lifesciences PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mega Lifesciences PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.